Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of an active 30-day surgical site infection surveillance at a tertiary hospital in Ghana: evidence from HAI-Ghana study.
Otieku, Evans; Fenny, Ama Pokuaa; Asante, Felix Ankomah; Bediako-Bowan, Antoinette; Enemark, Ulrika.
Afiliação
  • Otieku E; Economics Division, Institute of Statistical, Social and Economic Research, University of Ghana, Legon, Greater Accra, Ghana otieku@yahoo.com.
  • Fenny AP; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Asante FA; Economics Division, Institute of Statistical, Social and Economic Research, University of Ghana, Legon, Greater Accra, Ghana.
  • Bediako-Bowan A; Economics Division, Institute of Statistical, Social and Economic Research, University of Ghana, Legon, Greater Accra, Ghana.
  • Enemark U; Department of Surgery, Korle Bu Teaching Hospital, Accra, Ghana.
BMJ Open ; 12(1): e057468, 2022 01 03.
Article em En | MEDLINE | ID: mdl-34980632
OBJECTIVE: To assess the cost-effectiveness of an active 30-day surgical site infection (SSI) surveillance mechanism at a referral teaching hospital in Ghana using data from healthcare-associated infection Ghana (HAI-Ghana) study. DESIGN: Before and during intervention study using economic evaluation model to assess the cost-effectiveness of an active 30-day SSI surveillance at a teaching hospital. The intervention involves daily inspection of surgical wound area for 30-day postsurgery with quarterly feedback provided to surgeons. Discharged patients were followed up by phone call on postoperative days 3, 15 and 30 using a recommended surgical wound healing postdischarge questionnaire. SETTING: Korle-Bu Teaching Hospital (KBTH), Ghana. PARTICIPANTS: All prospective patients who underwent surgical procedures at the general surgical unit of the KBTH. MAIN OUTCOME MEASURES: The primary outcome measures were the avoidable SSI morbidity risk and the associated costs from patient and provider perspectives. We also reported three indicators of SSI severity, that is, length of hospital stay (LOS), number of outpatient visits and laboratory tests. The analysis was performed in STATA V.14 and Microsoft Excel. RESULTS: Before-intervention SSI risk was 13.9% (62/446) as opposed to during-intervention 8.4% (49/582), equivalent to a risk difference of 5.5% (95% CI 5.3 to 5.9). SSI mortality risk decreased by 33.3% during the intervention while SSI-attributable LOS decreased by 32.6%. Furthermore, the mean SSI-attributable patient direct and indirect medical cost declined by 12.1% during intervention while the hospital costs reduced by 19.1%. The intervention led to an estimated incremental cost-effectiveness ratio of US$4196 savings per SSI episode avoided. At a national scale, this could be equivalent to a US$60 162 248 cost advantage annually. CONCLUSION: The intervention is a simple, cost-effective, sustainable and adaptable strategy that may interest policymakers and health institutions interested in reducing SSI.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecção da Ferida Cirúrgica / Assistência ao Convalescente Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecção da Ferida Cirúrgica / Assistência ao Convalescente Idioma: En Ano de publicação: 2022 Tipo de documento: Article